Temozolomide induces senescence but not apoptosis in human melanoma cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2007-10-30

AUTHORS

N M Mhaidat, X D Zhang, J Allen, K A Avery-Kiejda, R J Scott, P Hersey

ABSTRACT

Temozolomide (TMZ), a DNA alkylating agent used in the treatment of melanoma, is believed to mediate its effect by addition of a methyl group to the O6 position of guanine in DNA. Resistance to the agent may be in part due to the activity of O6-methylguanine-DNA methyl transferase (MGMT). In the present study, we show that sensitivity of melanoma cells to TMZ was dependent on their p53 status and levels of MGMT. Analysis of the mechanisms underlying reduced viability showed no evidence for induction of apoptosis even though marked levels of apoptosis was seen in TK6 lymphoma cells. Sensitivity of melanoma cells was associated with p53-dependent G2/M cell cycle arrest and induction of senescence. To verify the role of p53, the assays were repeated in presence of pifithrin-α, an inhibitor of p53. This resulted in increased viability of melanoma cells with wild-type p53 and reversed G2/M cell cycle arrest. Paradoxically, apoptosis was increased in melanoma but decreased as expected in TK6 lymphoma cells. These results are consistent with the view that TMZ is relatively ineffective against melanoma due to defective apoptotic signalling resulting from activation of p53. The nature of the defects in apoptotic signalling remains to be explored. More... »

PAGES

1225-1233

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604017

DOI

http://dx.doi.org/10.1038/sj.bjc.6604017

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020206627

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17968428


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzothiazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cellular Senescence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "G2 Phase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "O(6)-Methylguanine-DNA Methyltransferase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Temozolomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Toluene", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mhaidat", 
        "givenName": "N M", 
        "id": "sg:person.01322140110.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322140110.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "X D", 
        "id": "sg:person.01210116316.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centenary Institute of Cancer Medicine and Biology, University of Sydney, 2050, Camperdown, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1013.3", 
          "name": [
            "Centenary Institute of Cancer Medicine and Biology, University of Sydney, 2050, Camperdown, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Allen", 
        "givenName": "J", 
        "id": "sg:person.01201327350.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201327350.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Avery-Kiejda", 
        "givenName": "K A", 
        "id": "sg:person.01077011303.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077011303.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Discipline of Medical Genetics, School of Biomedical Sciences, Faculty of Health, University of Newcastle, 2300, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "Discipline of Medical Genetics, School of Biomedical Sciences, Faculty of Health, University of Newcastle, 2300, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scott", 
        "givenName": "R J", 
        "id": "sg:person.01270537012.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270537012.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hersey", 
        "givenName": "P", 
        "id": "sg:person.01073667716.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6690802", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004242301", 
          "https://doi.org/10.1038/sj.bjc.6690802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011233561", 
          "https://doi.org/10.1038/sj.bjc.6603525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/74994", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019830643", 
          "https://doi.org/10.1038/74994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6600711", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053673290", 
          "https://doi.org/10.1038/sj.bjc.6600711"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-10-30", 
    "datePublishedReg": "2007-10-30", 
    "description": "Temozolomide (TMZ), a DNA alkylating agent used in the treatment of melanoma, is believed to mediate its effect by addition of a methyl group to the O6 position of guanine in DNA. Resistance to the agent may be in part due to the activity of O6-methylguanine-DNA methyl transferase (MGMT). In the present study, we show that sensitivity of melanoma cells to TMZ was dependent on their p53 status and levels of MGMT. Analysis of the mechanisms underlying reduced viability showed no evidence for induction of apoptosis even though marked levels of apoptosis was seen in TK6 lymphoma cells. Sensitivity of melanoma cells was associated with p53-dependent G2/M cell cycle arrest and induction of senescence. To verify the role of p53, the assays were repeated in presence of pifithrin-\u03b1, an inhibitor of p53. This resulted in increased viability of melanoma cells with wild-type p53 and reversed G2/M cell cycle arrest. Paradoxically, apoptosis was increased in melanoma but decreased as expected in TK6 lymphoma cells. These results are consistent with the view that TMZ is relatively ineffective against melanoma due to defective apoptotic signalling resulting from activation of p53. The nature of the defects in apoptotic signalling remains to be explored.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6604017", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "97"
      }
    ], 
    "keywords": [
      "G2/M cell cycle arrest", 
      "M cell cycle arrest", 
      "melanoma cells", 
      "cell cycle arrest", 
      "lymphoma cells", 
      "cycle arrest", 
      "treatment of melanoma", 
      "levels of MGMT", 
      "human melanoma cells", 
      "level of apoptosis", 
      "role of p53", 
      "presence of pifithrin", 
      "inhibitor of p53", 
      "apoptotic signaling", 
      "activation of p53", 
      "induction of senescence", 
      "induction of apoptosis", 
      "temozolomide", 
      "p53 status", 
      "wild-type p53", 
      "melanoma", 
      "p53", 
      "apoptosis", 
      "O6-methylguanine-DNA methyl transferase", 
      "present study", 
      "cells", 
      "arrest", 
      "reduced viability", 
      "induction", 
      "signaling", 
      "agents", 
      "O6 position", 
      "pifithrin", 
      "methyl transferase", 
      "MGMT", 
      "treatment", 
      "levels", 
      "viability", 
      "senescence", 
      "inhibitors", 
      "activation", 
      "sensitivity", 
      "status", 
      "assays", 
      "group", 
      "transferase", 
      "DNA", 
      "evidence", 
      "activity", 
      "study", 
      "role", 
      "defects", 
      "effect", 
      "resistance", 
      "presence", 
      "mechanism", 
      "guanine", 
      "addition", 
      "analysis", 
      "results", 
      "part", 
      "view", 
      "position", 
      "nature", 
      "methyl group"
    ], 
    "name": "Temozolomide induces senescence but not apoptosis in human melanoma cells", 
    "pagination": "1225-1233", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020206627"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604017"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17968428"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604017", 
      "https://app.dimensions.ai/details/publication/pub.1020206627"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_454.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6604017"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604017'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604017'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604017'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604017'


 

This table displays all metadata directly associated to this object as RDF triples.

243 TRIPLES      21 PREDICATES      109 URIs      97 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604017 schema:about N0655719310bc4f1493647cb6bf2cddfb
2 N0c3df745d18c4aeab0308d2c771262de
3 N2f19cd8110db4cbda3b5b81e51d54b76
4 N32a7a2dcd4684c65ba7f3ed9103240a3
5 N35d10ce3cc074c7588be26c828c76c19
6 N482079797be14cf1b4754710c18bd5e3
7 N54c49ff9b89c4347a801ffbc49804feb
8 N9677daee94984b7a827a35938a36720c
9 Na6cbffcdaec94bc784815885a6458151
10 Nada718e087e04f75819fbc44537d5d80
11 Nb9bac8e7a58a4c6ea2737c07682af4be
12 Nbe0224310a154677b9e8b24950d4740e
13 Ncc9691d1ef264706b0ce94db4539137d
14 Nd7449070a996468a9358594a6e793edf
15 Ne4b66c950c914fd785e7e565aa195631
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N870581dd56134b859efb35c910f1d2a8
19 schema:citation sg:pub.10.1038/74994
20 sg:pub.10.1038/sj.bjc.6600711
21 sg:pub.10.1038/sj.bjc.6603525
22 sg:pub.10.1038/sj.bjc.6690802
23 schema:datePublished 2007-10-30
24 schema:datePublishedReg 2007-10-30
25 schema:description Temozolomide (TMZ), a DNA alkylating agent used in the treatment of melanoma, is believed to mediate its effect by addition of a methyl group to the O6 position of guanine in DNA. Resistance to the agent may be in part due to the activity of O6-methylguanine-DNA methyl transferase (MGMT). In the present study, we show that sensitivity of melanoma cells to TMZ was dependent on their p53 status and levels of MGMT. Analysis of the mechanisms underlying reduced viability showed no evidence for induction of apoptosis even though marked levels of apoptosis was seen in TK6 lymphoma cells. Sensitivity of melanoma cells was associated with p53-dependent G2/M cell cycle arrest and induction of senescence. To verify the role of p53, the assays were repeated in presence of pifithrin-α, an inhibitor of p53. This resulted in increased viability of melanoma cells with wild-type p53 and reversed G2/M cell cycle arrest. Paradoxically, apoptosis was increased in melanoma but decreased as expected in TK6 lymphoma cells. These results are consistent with the view that TMZ is relatively ineffective against melanoma due to defective apoptotic signalling resulting from activation of p53. The nature of the defects in apoptotic signalling remains to be explored.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf Nc2ce9197fc9e4618b044bb97f41afb7c
29 Nf98a90128e4e46bbbc9784044f671ed9
30 sg:journal.1017082
31 schema:keywords DNA
32 G2/M cell cycle arrest
33 M cell cycle arrest
34 MGMT
35 O6 position
36 O6-methylguanine-DNA methyl transferase
37 activation
38 activation of p53
39 activity
40 addition
41 agents
42 analysis
43 apoptosis
44 apoptotic signaling
45 arrest
46 assays
47 cell cycle arrest
48 cells
49 cycle arrest
50 defects
51 effect
52 evidence
53 group
54 guanine
55 human melanoma cells
56 induction
57 induction of apoptosis
58 induction of senescence
59 inhibitor of p53
60 inhibitors
61 level of apoptosis
62 levels
63 levels of MGMT
64 lymphoma cells
65 mechanism
66 melanoma
67 melanoma cells
68 methyl group
69 methyl transferase
70 nature
71 p53
72 p53 status
73 part
74 pifithrin
75 position
76 presence
77 presence of pifithrin
78 present study
79 reduced viability
80 resistance
81 results
82 role
83 role of p53
84 senescence
85 sensitivity
86 signaling
87 status
88 study
89 temozolomide
90 transferase
91 treatment
92 treatment of melanoma
93 viability
94 view
95 wild-type p53
96 schema:name Temozolomide induces senescence but not apoptosis in human melanoma cells
97 schema:pagination 1225-1233
98 schema:productId N20e52f6972b24ff4bb4053d00e424347
99 Nd30c8d04e04d4a6e8ba5ec98c66034c9
100 Nfe5bcec177024fa4b9689d68993152f8
101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020206627
102 https://doi.org/10.1038/sj.bjc.6604017
103 schema:sdDatePublished 2022-10-01T06:34
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher N750f7236aea5475fa9d64418280c302e
106 schema:url https://doi.org/10.1038/sj.bjc.6604017
107 sgo:license sg:explorer/license/
108 sgo:sdDataset articles
109 rdf:type schema:ScholarlyArticle
110 N0655719310bc4f1493647cb6bf2cddfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name O(6)-Methylguanine-DNA Methyltransferase
112 rdf:type schema:DefinedTerm
113 N0c3df745d18c4aeab0308d2c771262de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Cell Division
115 rdf:type schema:DefinedTerm
116 N19a9d25aadb54333aad0aac7187d18c8 rdf:first sg:person.01201327350.70
117 rdf:rest N33e28c0934af4c5aadc660680b88abd3
118 N20e52f6972b24ff4bb4053d00e424347 schema:name dimensions_id
119 schema:value pub.1020206627
120 rdf:type schema:PropertyValue
121 N2f19cd8110db4cbda3b5b81e51d54b76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Tumor Cells, Cultured
123 rdf:type schema:DefinedTerm
124 N32a7a2dcd4684c65ba7f3ed9103240a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Lymphoma
126 rdf:type schema:DefinedTerm
127 N33e28c0934af4c5aadc660680b88abd3 rdf:first sg:person.01077011303.24
128 rdf:rest Nb3f764f98cb64a33a3720e12fae28091
129 N35d10ce3cc074c7588be26c828c76c19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Benzothiazoles
131 rdf:type schema:DefinedTerm
132 N482079797be14cf1b4754710c18bd5e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Melanoma
134 rdf:type schema:DefinedTerm
135 N54c49ff9b89c4347a801ffbc49804feb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name G2 Phase
137 rdf:type schema:DefinedTerm
138 N5f28428fed6a461391ce6cbb7d0794a8 rdf:first sg:person.01210116316.18
139 rdf:rest N19a9d25aadb54333aad0aac7187d18c8
140 N750f7236aea5475fa9d64418280c302e schema:name Springer Nature - SN SciGraph project
141 rdf:type schema:Organization
142 N870581dd56134b859efb35c910f1d2a8 rdf:first sg:person.01322140110.30
143 rdf:rest N5f28428fed6a461391ce6cbb7d0794a8
144 N9677daee94984b7a827a35938a36720c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Toluene
146 rdf:type schema:DefinedTerm
147 Na6cbffcdaec94bc784815885a6458151 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 Nada718e087e04f75819fbc44537d5d80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Temozolomide
152 rdf:type schema:DefinedTerm
153 Nb3f764f98cb64a33a3720e12fae28091 rdf:first sg:person.01270537012.68
154 rdf:rest Nf6d1dc5aa418471b9d04a268b1d0bf79
155 Nb9bac8e7a58a4c6ea2737c07682af4be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Apoptosis
157 rdf:type schema:DefinedTerm
158 Nbe0224310a154677b9e8b24950d4740e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Antineoplastic Agents, Alkylating
160 rdf:type schema:DefinedTerm
161 Nc2ce9197fc9e4618b044bb97f41afb7c schema:issueNumber 9
162 rdf:type schema:PublicationIssue
163 Ncc9691d1ef264706b0ce94db4539137d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Dacarbazine
165 rdf:type schema:DefinedTerm
166 Nd30c8d04e04d4a6e8ba5ec98c66034c9 schema:name doi
167 schema:value 10.1038/sj.bjc.6604017
168 rdf:type schema:PropertyValue
169 Nd7449070a996468a9358594a6e793edf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Cellular Senescence
171 rdf:type schema:DefinedTerm
172 Ne4b66c950c914fd785e7e565aa195631 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Tumor Suppressor Protein p53
174 rdf:type schema:DefinedTerm
175 Nf6d1dc5aa418471b9d04a268b1d0bf79 rdf:first sg:person.01073667716.42
176 rdf:rest rdf:nil
177 Nf98a90128e4e46bbbc9784044f671ed9 schema:volumeNumber 97
178 rdf:type schema:PublicationVolume
179 Nfe5bcec177024fa4b9689d68993152f8 schema:name pubmed_id
180 schema:value 17968428
181 rdf:type schema:PropertyValue
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
186 schema:name Oncology and Carcinogenesis
187 rdf:type schema:DefinedTerm
188 sg:journal.1017082 schema:issn 0007-0920
189 1532-1827
190 schema:name British Journal of Cancer
191 schema:publisher Springer Nature
192 rdf:type schema:Periodical
193 sg:person.01073667716.42 schema:affiliation grid-institutes:None
194 schema:familyName Hersey
195 schema:givenName P
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42
197 rdf:type schema:Person
198 sg:person.01077011303.24 schema:affiliation grid-institutes:None
199 schema:familyName Avery-Kiejda
200 schema:givenName K A
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077011303.24
202 rdf:type schema:Person
203 sg:person.01201327350.70 schema:affiliation grid-institutes:grid.1013.3
204 schema:familyName Allen
205 schema:givenName J
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201327350.70
207 rdf:type schema:Person
208 sg:person.01210116316.18 schema:affiliation grid-institutes:None
209 schema:familyName Zhang
210 schema:givenName X D
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18
212 rdf:type schema:Person
213 sg:person.01270537012.68 schema:affiliation grid-institutes:grid.266842.c
214 schema:familyName Scott
215 schema:givenName R J
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270537012.68
217 rdf:type schema:Person
218 sg:person.01322140110.30 schema:affiliation grid-institutes:None
219 schema:familyName Mhaidat
220 schema:givenName N M
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322140110.30
222 rdf:type schema:Person
223 sg:pub.10.1038/74994 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019830643
224 https://doi.org/10.1038/74994
225 rdf:type schema:CreativeWork
226 sg:pub.10.1038/sj.bjc.6600711 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053673290
227 https://doi.org/10.1038/sj.bjc.6600711
228 rdf:type schema:CreativeWork
229 sg:pub.10.1038/sj.bjc.6603525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011233561
230 https://doi.org/10.1038/sj.bjc.6603525
231 rdf:type schema:CreativeWork
232 sg:pub.10.1038/sj.bjc.6690802 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004242301
233 https://doi.org/10.1038/sj.bjc.6690802
234 rdf:type schema:CreativeWork
235 grid-institutes:None schema:alternateName Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia
236 schema:name Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia
237 rdf:type schema:Organization
238 grid-institutes:grid.1013.3 schema:alternateName Centenary Institute of Cancer Medicine and Biology, University of Sydney, 2050, Camperdown, New South Wales, Australia
239 schema:name Centenary Institute of Cancer Medicine and Biology, University of Sydney, 2050, Camperdown, New South Wales, Australia
240 rdf:type schema:Organization
241 grid-institutes:grid.266842.c schema:alternateName Discipline of Medical Genetics, School of Biomedical Sciences, Faculty of Health, University of Newcastle, 2300, New South Wales, Australia
242 schema:name Discipline of Medical Genetics, School of Biomedical Sciences, Faculty of Health, University of Newcastle, 2300, New South Wales, Australia
243 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...